Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Interactive Strength Inc. (Nasdaq:TRNR)'s FORME Named an Exclusive Wellness Partner for Virgin Atlantic's New Clubhouse at LAX
Healthcare & PharmaceuticalPartnerships

Interactive Strength Inc. (Nasdaq:TRNR)'s FORME Named an Exclusive Wellness Partner for Virgin Atlantic's New Clubhouse at LAX

March 27, 2025 5:15 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the FORME and CLMBR brands, today announced that FORME has been selected as an exclusive wellness partner for Virgin Atlantic's newly launched Clubhouse at Los Angeles International Airport (LAX).The partnership places the award-winning FORME Studio at the center of Virgin Atlantic's new Zen Den, an immersive wellness space...

Read more
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
Healthcare & PharmaceuticalProduct Announcements

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

March 27, 2025 4:30 PM

CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced that the European Patent Office (EPO) has confirmed the validity of CureVac's European patent EP 3 708 668 B1 subject to amendments to specify the scope of protection. Following today's hearing, the opposition division largely dismissed the opposition...

Read more
Why Modern Medicine is Failing Chronic Illness Patients - And What Needs to Change
Healthcare & PharmaceuticalCompany Update

Why Modern Medicine is Failing Chronic Illness Patients - And What Needs to Change

March 27, 2025 4:15 PM

Dr. Brian Anderson Shares His Insights on the Shortcomings of Conventional Healthcare in Addressing Chronic Conditions and Why Cellular Health is the Missing Link to Real RecoveryFor decades, the conventional healthcare system has been the go-to solution for individuals struggling with chronic illnesses. Yet, despite the trillions of dollars poured into modern medicine, millions of people remain trapped in a cycle of medication dependency,...

Read more
French Pharmacy Expands Access to Dermatologist-Approved Skincare in the U.S
Healthcare & PharmaceuticalCompany Update

French Pharmacy Expands Access to Dermatologist-Approved Skincare in the U.S

March 27, 2025 4:15 PM

French Pharmacy, a provider of French skincare products in the U.S., offers a range of dermatologically tested and science-backed formulations. Featuring brands such as La Roche-Posay, Avène, and Bioderma, the company focuses on research-driven skincare solutions for various skin concerns. The company recently launched a full line of skincare products formulated using the clinically tested ingredients that French skincare is known for. ...

Read more
Alter Behavioral Health Offers Free Counseling for Los Angeles Fire Victims
Healthcare & PharmaceuticalCompany Update

Alter Behavioral Health Offers Free Counseling for Los Angeles Fire Victims

March 27, 2025 9:00 AM

Alter Behavioral Health is offering free counseling to Los Angeles fire victims. Many face anxiety, PTSD, and sleepless nights. Without help, these struggles can grow worse. Alter aims to remove financial and logistical barriers to mental health care, ensuring survivors receive immediate support."Wildfires do more than burn homes. They leave behind stress, fear, and trauma. Some survivors battle depression and panic attacks. Others struggle to...

Read more
Candid Health Successfully Completed a Type 1 SOC 2 Examination With an Unqualified Opinion
Healthcare & PharmaceuticalCompany Update

Candid Health Successfully Completed a Type 1 SOC 2 Examination With an Unqualified Opinion

March 27, 2025 9:00 AM

Candid Health, the revenue cycle automation platform for healthcare providers, today announced that it has successfully completed a Type 1 System and Organization Controls 2 (SOC 2) examination for its Revenue Cycle Automation Platform as of December 2, 2024. The examination conducted by AssurancePoint, LLC (www.assurancepoint.cpa) found that Candid Health achieved its service commitments and system requirements as measured by the SOC 2 criteria...

Read more
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
Healthcare & PharmaceuticalEarnings

CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

March 27, 2025 9:00 AM

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2024.Fiscal 2024, Fourth Quarter 2024 and Recent Financial and Operating HighlightsGenerated...

Read more
Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
Healthcare & PharmaceuticalCompany Update

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study

March 27, 2025 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") family company Napo Pharmaceuticals ("Napo") today announced that the U.S. Food and Drug Administration (FDA) has granted Napo a Type C Meeting in the second quarter of 2025 to discuss the responder analysis in the prespecified subgroup of patients with breast cancer for crofelemer in Napo's Phase 3 OnTarget trial. Patients with breast cancer accounted for 183 of the 287 participants...

Read more
CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement
Healthcare & PharmaceuticalCompany Update

CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement

March 27, 2025 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL) is making waves in the booming health and wellness industry with the launch of its latest breakthrough product: Passion Fuel Cordyceps Complex. This cutting-edge supplement is designed to supercharge libido, enhance stamina, improve blood flow, and optimize overall performance, providing an all-natural solution for individuals looking to elevate their intimate and athletic experiences.Each serving of...

Read more
NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors
Healthcare & PharmaceuticalCompany Update

NHI Announces Appointment of Robert W. Chapin, Jr. to the Board of Directors

March 27, 2025 7:00 AM

National Health Investors, Inc. (NYSE:NHI) (the "Company" or "NHI") announced today that Robert W. Chapin, Jr. is joining the NHI Board of Directors (the "Board") effective immediately.Mr. Chapin has been appointed to the Board's special committee of disinterested directors to negotiate, review, analyze and approve any potential lease between NHI and NHC and all related items or explore any other possible alternatives.Mr. Chapin has served in...

Read more
Bionic Bloom Presents: Cannadelic Miami 2025 Announces Featured Vendor
Healthcare & PharmaceuticalCompany Update

Bionic Bloom Presents: Cannadelic Miami 2025 Announces Featured Vendor

March 27, 2025 7:00 AM

As Title Sponsor of Cannadelic Miami 2025, Bionic Bloom is proud to announce Sacred Bloom College of Healing Arts as a featured vendor at the world's largest cannabis and psychedelics conference and expo, taking place May 23-24, 2025, at the Miami Airport Convention Center.Founded by Dr. Angela Fisher, the visionary behind Bionic Bloom and a national leader in integrative mental health, Sacred Bloom College of Healing Arts is an emerging...

Read more
Bausch Health to Announce First Quarter Results on April 30
Healthcare & PharmaceuticalEarnings

Bausch Health to Announce First Quarter Results on April 30

March 27, 2025 7:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call DetailsDate: Wednesday,...

Read more
DEA Delays Threaten U.S. Leadership in Global Cannabis Pharma Market Despite FDA Advances
Healthcare & PharmaceuticalCompany Update

DEA Delays Threaten U.S. Leadership in Global Cannabis Pharma Market Despite FDA Advances

March 27, 2025 4:00 AM

The U.S. Food and Drug Administration (FDA) has provided critical feedback on MMJ International Holdings' Investigational New Drug (IND) application for MMJ-002, charting a clear course for the advancement of clinical trials. This development marks a significant step forward in the battle against Huntington's disease. However, the Drug Enforcement Administration (DEA) has yet to issue an API Bulk Manufacturing Registration, essential for legally...

Read more
IRLAB to Initiate a Study of IRL757 in Parkinsons’s Disease with Full Financial Backing from its Development Partner MSRD
Healthcare & PharmaceuticalCompany Update

IRLAB to Initiate a Study of IRL757 in Parkinsons’s Disease with Full Financial Backing from its Development Partner MSRD

March 27, 2025 2:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that its drug candidate IRL757 will be advanced into the next stage with a clinical study in patients with Parkinson's disease suffering from apathy. The financing of startup cost of the study will be covered by the McQuade Center for Strategic Research and Development (MSRD) through an initial payment to...

Read more
Med Holdings Group Inc. (OTC PINK:YUKA) and MedSmart Wellness Centers Inc. Announce Strategic Partnerships with Well-Known Hotels and Crunch Fitness
Healthcare & PharmaceuticalCompany Update

Med Holdings Group Inc. (OTC PINK:YUKA) and MedSmart Wellness Centers Inc. Announce Strategic Partnerships with Well-Known Hotels and Crunch Fitness

March 26, 2025 10:08 PM

Med Holdings Group Inc. (OTC PINK:YUKA) and its subsidiary, MedSmart Wellness Centers Inc., are excited to announce strategic partnership agreements with two well-known hotels in Aventura, as well as with Crunch Fitness Inc. at their new 120,000-square-foot facility located in Hallandale Beach, Florida.These partnerships will improve the accessibility and convenience of MedSmart Wellness Centers' top-tier wellness and recovery treatments for...

Read more
Electronic Caregiver's Addison Care Virtual Solutions Reduce Financial and Health Risks for Independent and Assisted Living Communities
Healthcare & PharmaceuticalProduct Announcements

Electronic Caregiver's Addison Care Virtual Solutions Reduce Financial and Health Risks for Independent and Assisted Living Communities

March 26, 2025 6:40 PM

Electronic Caregiver Inc., a leading innovator in virtual care technology, is transforming the way independent living (IL) and assisted living (AL) communities manage health risks, operational costs, and resident safety. Through Addison Care, the company's AI-driven virtual caregiver, senior housing operators can proactively combat the financial and health burdens caused by preventable medical emergencies, infectious disease outbreaks, and...

Read more
Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Healthcare & PharmaceuticalCompany Update

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile

March 26, 2025 6:00 PM

Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology") in combination with radiation therapy, which has demonstrated, in a December 2021 study[1] conducted by researchers at the University of Alberta, Canada, effective targeting of...

Read more
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
Healthcare & PharmaceuticalProduct Announcements

CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods

March 26, 2025 4:30 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced the launch of Lunar Fox™ Food Co., an all-new line of plant-based foods, offering sustainable, vegetarian-friendly nutrition alternatives for our customers. Lunar Fox™ Food Co. products are 100% natural, gluten...

Read more
InteliChart Named #1 End-to-End Patient Engagement Solution for Third Consecutive Year in Black Book(TM) 2025 Survey
Healthcare & PharmaceuticalAwards

InteliChart Named #1 End-to-End Patient Engagement Solution for Third Consecutive Year in Black Book(TM) 2025 Survey

March 26, 2025 4:00 PM

Black Book Market Research LLC, a leading independent healthcare IT survey and polling organization, today released the results of its annual 2025 Patient Engagement and Healthcare Consumer Communication Technologies Survey. The nationwide study, conducted over a six-month period, captured insights from 2,518 verified users, including clinical, administrative, and IT professionals across the care continuum, as well as more than 1,000 healthcare...

Read more
StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant
Healthcare & PharmaceuticalCompany Update

StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant

March 26, 2025 4:00 PM

StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, is pleased to provide a progress report on the redesign of its flagship eBalance® microcurrent therapeutic device. StimCell also announced the settlement of outstanding indebtedness owed to an arms-length third party for shares of its common stock and the engagement of a third party...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?